Showing results (1291-1300 of 1,360) with videos related to

Sort By:
Pageof 136
Nature Immunology|December 22, 2020
The receptor DNGR-1 signals for phagosomal rupture to promote cross-presentation of dead-cell-associated antigensJohnathan Canton, Hanna Blees, Conor M Henry, et al.
Diabetes Care|August 27, 2011
The Charcot foot in diabetesLee C Rogers, Robert G Frykberg, David G Armstrong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2004
Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: a pediatric intergroup study--Pediatric Oncology Group 9049 and Children's Cancer Group 8882Barbara Cushing, Roger Giller, John W Cullen, et al.
Research on Child and Adolescent Psychopathology|April 1, 2024
Does the Relationship between Age and Brain Structure Differ in Youth with Conduct Disorder?Sarah Koerner, Marlene Staginnus, Harriet Cornwell, et al.
Scientific Reports|July 31, 2019
Roux-Y Gastric Bypass and Sleeve Gastrectomy directly change gut microbiota composition independent of surgery typeFernanda L Paganelli, Misha Luyer, C Marijn Hazelbag, et al.
Nature|October 25, 2014
Dendritic cells control fibroblastic reticular network tension and lymph node expansionSophie E Acton, Aaron J Farrugia, Jillian L Astarita, et al.
Depression and Anxiety|September 8, 2021
Age and sex-related variability in the presentation of generalized anxiety and depression symptomsKatherine N Thompson, Christopher Hübel, Rosa Cheesman, et al.
The Journal of Cell Biology|April 12, 2023
PIM1 phosphorylates ABI2 to enhance actin dynamics and promote tumor invasionCorbin C Jensen, Amber N Clements, Hope Liou, et al.
The Oncologist|June 29, 2026
Use of liposomal irinotecan with 5-FU and oxaliplatin (NALIRIFOX) in neoadjuvant pancreatic adenocarcinoma: NEO-Nal-IRI trialThomas J George, Tuo Lin, Ibrahim Nassour, et al.
Journal of Proteome Research|November 11, 2009
Quantitative phosphoproteomic analysis of the STAT3/IL-6/HIF1alpha signaling network: an initial study in GSC11 glioblastoma stem cellsCarol L Nilsson, Roslyn Dillon, Arugadoss Devakumar, et al.
Pageof 136